Gemelli, M.; Doulamis, I.P.; Rojanathagoon, T.; Tzani, A.; Rempakos, A.; Kampaktsis, P.; Guariento, A.; Ruiz Dunque, E.; Asleh, R.; Alvarez, P.;
et al. Outcomes of Use of Inotropes at Waitlisting Through Heart Transplantation: The UNOS Experience. J. Cardiovasc. Dev. Dis. 2025, 12, 364.
https://doi.org/10.3390/jcdd12090364
AMA Style
Gemelli M, Doulamis IP, Rojanathagoon T, Tzani A, Rempakos A, Kampaktsis P, Guariento A, Ruiz Dunque E, Asleh R, Alvarez P,
et al. Outcomes of Use of Inotropes at Waitlisting Through Heart Transplantation: The UNOS Experience. Journal of Cardiovascular Development and Disease. 2025; 12(9):364.
https://doi.org/10.3390/jcdd12090364
Chicago/Turabian Style
Gemelli, Marco, Ilias P. Doulamis, Thanakorn Rojanathagoon, Aspasia Tzani, Athanasios Rempakos, Polydoros Kampaktsis, Alvise Guariento, Ernesto Ruiz Dunque, Rabea Asleh, Paulino Alvarez,
and et al. 2025. "Outcomes of Use of Inotropes at Waitlisting Through Heart Transplantation: The UNOS Experience" Journal of Cardiovascular Development and Disease 12, no. 9: 364.
https://doi.org/10.3390/jcdd12090364
APA Style
Gemelli, M., Doulamis, I. P., Rojanathagoon, T., Tzani, A., Rempakos, A., Kampaktsis, P., Guariento, A., Ruiz Dunque, E., Asleh, R., Alvarez, P., Tarzia, V., Gerosa, G., & Briasoulis, A.
(2025). Outcomes of Use of Inotropes at Waitlisting Through Heart Transplantation: The UNOS Experience. Journal of Cardiovascular Development and Disease, 12(9), 364.
https://doi.org/10.3390/jcdd12090364